DarioHealth Corp.
DRIOHealthcareNASDAQHealth Information Services · Last scanned Oct 26, 2026
Scan Results
Daily timeframePart of the healthcare sector, DarioHealth Corp. (DRIO) is listed under Health Information Services. The company carries a $36.9M market cap, placing it firmly in the micro-cap category. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Market Cap
$36.9M
Beta
1.18
P/E (TTM)
—
P/E (Fwd)
-3.37
EPS (TTM)
$-2.28
EPS (Fwd)
$-1.12
ROE
-59.9%
ROA
-19.4%
Cash
$14.0M
Total Debt
$32.4M
Free CF
-$12.3M
52W Change
-76.1%
Annual Financials
Cash vs Debt
Where DRIO stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, DRIO finished 37.55% below its 150-day moving average ($7.19) and 44.77% below its 200-day moving average ($8.13). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is DRIO overbought or oversold?
At the October 20, 2026 close, DRIO's RSI(14) was 25.1, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, DRIO has $14.0M in cash with $32.4M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company is burning cash, with free cash flow at -$12.3M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -59.9%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $27.7M (2022) to $22.4M (2025), a 19% decline worth watching.
The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for DarioHealth Corp. and its sector.